发明名称 Compound containing basic group and use thereof
摘要 The present invention relates to a compound represented by formula (I-0):; wherein symbols in formula have the same meanings as described in the present specification, a salt thereof, an N-oxide thereof or a solvate thereof or a prodrug thereof, and medical use thereof. ;The compound of the present invention has an antagonistic activity against CXCR4 and is therefore useful as a preventive and/or therapeutic agent for CXCR4-mediated diseases, for example, inflammatory and immune diseases (for example, rheumatoid arthritis, arthritis, retinopathy, pulmonary fibrosis, transplanted organ rejection, etc.), allergic diseases, infections (for example, human immunodeficiency virus infection, acquired immunodeficiency syndrome, etc.), psychoneurotic diseases, cerebral diseases, cardiovascular disease, metabolic diseases, and cancerous diseases (for example, cancer, cancer metastasis, etc.), or an agent for regeneration therapy.
申请公布号 US8822459(B2) 申请公布日期 2014.09.02
申请号 US201113027957 申请日期 2011.02.15
申请人 Ono Pharmaceutical Co., Ltd. 发明人 Kokubo Masaya;Takaoka Yoshikazu;Shibayama Shiro
分类号 A61K31/535;C07D265/28;C07D471/10;C07D233/90;C07D401/14;C07D487/10;C07D233/16;C07D233/84;C07D403/12;C07D403/14 主分类号 A61K31/535
代理机构 Sughrue Mion, PLLC 代理人 Sughrue Mion, PLLC
主权项 1. A compound represented by formula (I-0): wherein A1 and A2 each independently represents an imidazole ring which may have a substituent(s); B1 and B2 each independently represents a methylene group which may have a substituent(s); E represents a phenylene which may have a substituent(s); L represents a —CO— or —CH2—; J0 represents 1-oxa-4,9-diazaspiro[5.5]undecane which may have a substituent(s); represents a single bond; D represents a nitrogen atom, G represents a —CO— or —CH2— or a salt thereof, an N-oxide thereof or a solvate thereof.
地址 Osaka JP